Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Sex hormones influence immune responses and may help treat diseases.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

IL-18 signaling helps mature Tregs move into the thymus.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

B cells can both help and hinder the body's defense against melanoma.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Improving nerve and immune interactions may help heal chronic wounds.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Statins may help treat alopecia areata by reducing harmful immune interactions.